Mar 31, 2023

Ventas Q1 2023 Earnings Report

Ventas's Q1 2023 performance was driven by SHOP and medical office buildings, emphasizing financial strength and flexibility.

Key Takeaways

Ventas reported solid first-quarter results, driven by SHOP and medical office buildings growth. The company reaffirmed its Normalized FFO guidance for the full year and remains focused on financial strength and flexibility. Ventas completed its plan to take ownership of the Santerre Portfolio and continues to focus on maximizing the value of the assets.

Ventas's Q1 results underscore strong momentum across the business.

SHOP led performance with outstanding top- and bottom-line growth.

Ventas is focused on financial strength and flexibility.

The company reaffirmed Normalized FFO guidance for the full year.

Total Revenue
$1.08B
Previous year: $1.02B
+5.8%
EPS
$0.74
Previous year: $0.79
-6.3%
Gross Profit
$468M
Previous year: $474M
-1.2%
Cash and Equivalents
$145M
Previous year: $150M
-2.8%
Total Assets
$24B
Previous year: $25B
-3.8%

Ventas

Ventas

Ventas Revenue by Segment

Forward Guidance

Ventas reaffirmed its previous full year guidance for Normalized FFO. The company also reaffirmed its guidance for net income attributable to common stockholders and Nareit FFO before the impact of purchase accounting adjustments and other GAAP impacts.

Revenue & Expenses

Visualization of income flow from segment revenue to net income